AR090930A1 - Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion - Google Patents

Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion

Info

Publication number
AR090930A1
AR090930A1 ARP130101515A ARP130101515A AR090930A1 AR 090930 A1 AR090930 A1 AR 090930A1 AR P130101515 A ARP130101515 A AR P130101515A AR P130101515 A ARP130101515 A AR P130101515A AR 090930 A1 AR090930 A1 AR 090930A1
Authority
AR
Argentina
Prior art keywords
compositions
desection
ophthalm
retention
protection against
Prior art date
Application number
ARP130101515A
Other languages
English (en)
Original Assignee
Alcon Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd
Publication of AR090930A1 publication Critical patent/AR090930A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Abstract

Una composición de lágrimas artificiales y composiciones oftálmicas adecuadas para administrar fármacos. En una realización, las composiciones comprenden un polímero de galactomanano tal como goma guar o hidroxipropil guar, ácido hialurónico y cis-diol tal como sorbitol. En una realización preferida, las composiciones también comprenden un compuesto de borato. Además, método de tratamiento.
ARP130101515A 2012-05-04 2013-05-03 Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion AR090930A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261642901P 2012-05-04 2012-05-04

Publications (1)

Publication Number Publication Date
AR090930A1 true AR090930A1 (es) 2014-12-17

Family

ID=48464107

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130101515A AR090930A1 (es) 2012-05-04 2013-05-03 Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion

Country Status (19)

Country Link
US (6) US20130296264A1 (es)
EP (1) EP2844226B1 (es)
KR (1) KR102076033B1 (es)
CN (2) CN104379131A (es)
AR (1) AR090930A1 (es)
AU (1) AU2013256144B2 (es)
BR (1) BR112014027582B1 (es)
CA (1) CA2872622C (es)
DK (1) DK2844226T3 (es)
ES (1) ES2761373T3 (es)
IN (1) IN2014MN02248A (es)
MX (1) MX362266B (es)
PH (1) PH12014502571A1 (es)
PL (1) PL2844226T3 (es)
PT (1) PT2844226T (es)
RU (1) RU2659207C2 (es)
UA (1) UA113434C2 (es)
WO (1) WO2013166399A1 (es)
ZA (1) ZA201408490B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3613423T (pt) 2013-07-10 2022-12-07 Matrix Biology Inst Composições de hialuronano de elevada elasticidade e suas utilizações
US10245324B2 (en) * 2014-10-31 2019-04-02 Johnson & Johnson Consumer Inc. Ophthalmic composition
CN105311042B (zh) * 2015-09-07 2019-04-12 广州国宇医药科技有限公司 一种糖醇组合物在制备治疗干眼症的药物中的应用
JP6948716B2 (ja) 2015-09-24 2021-10-13 マトリックス バイオロジー インスティテュート 高弾性ヒアルロナン組成物およびその使用の方法
US10632202B2 (en) 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
TW201938141A (zh) 2018-02-21 2019-10-01 瑞士商諾華公司 基於脂質的眼用乳劑
TWI757773B (zh) * 2019-06-28 2022-03-11 瑞士商愛爾康公司 眼用組成物
CN114191378A (zh) * 2021-11-23 2022-03-18 温州医科大学附属眼视光医院 一种地夸磷索缓释凝胶及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09227385A (ja) * 1996-02-29 1997-09-02 Ofutekusu:Kk 眼手術用補助剤
ATE250923T1 (de) 1997-07-29 2003-10-15 Alcon Lab Inc Galaktomannanpolymere und borat enthaltende augenarzneimittel
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
ZA200904917B (en) * 2007-02-09 2010-09-29 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
US20090036554A1 (en) * 2007-08-01 2009-02-05 Burke Susan E Ophthalmic compositions comprising a terpene compound
US9096819B2 (en) * 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
JP5659149B2 (ja) * 2008-04-26 2015-01-28 アルコン リサーチ， リミテッド ポリマー性人工涙液系
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
CN102939074A (zh) * 2010-05-05 2013-02-20 爱尔康研究有限公司 稳定的眼科半乳甘露聚糖制剂

Also Published As

Publication number Publication date
CN109157539A (zh) 2019-01-08
AU2013256144B2 (en) 2018-01-18
BR112014027582A8 (pt) 2021-06-15
DK2844226T3 (da) 2020-01-02
IN2014MN02248A (es) 2015-07-24
PT2844226T (pt) 2019-12-16
EP2844226A1 (en) 2015-03-11
CA2872622A1 (en) 2013-11-07
EP2844226B1 (en) 2019-11-13
US20130296264A1 (en) 2013-11-07
PH12014502571A1 (en) 2015-01-21
US11376275B2 (en) 2022-07-05
US11672820B2 (en) 2023-06-13
RU2659207C2 (ru) 2018-06-28
MX362266B (es) 2019-01-10
UA113434C2 (uk) 2017-01-25
US20220273699A1 (en) 2022-09-01
MX2014013444A (es) 2015-05-11
CN104379131A (zh) 2015-02-25
US20170136057A1 (en) 2017-05-18
US10828320B2 (en) 2020-11-10
KR102076033B1 (ko) 2020-02-11
ZA201408490B (en) 2016-08-31
US20230285443A1 (en) 2023-09-14
US20200138853A1 (en) 2020-05-07
US20210060056A1 (en) 2021-03-04
PL2844226T3 (pl) 2020-04-30
CA2872622C (en) 2020-07-28
KR20150003868A (ko) 2015-01-09
ES2761373T3 (es) 2020-05-19
AU2013256144A1 (en) 2014-12-04
BR112014027582A2 (pt) 2017-06-27
WO2013166399A1 (en) 2013-11-07
BR112014027582B1 (pt) 2022-05-10
RU2014148758A (ru) 2016-06-27

Similar Documents

Publication Publication Date Title
AR090930A1 (es) Composiciones oftalmicas con proteccion mejorada contra la desecacion y retencion
AR112286A2 (es) Sistema polimérico de lágrimas artificiales
CL2013002134A1 (es) Composicion farmaceutica oftalmica de administracion topica que comprende un androgeno; y metodo para tratar una afeccion ocular resultante de una deficiencia de androgeno.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
EA201590053A1 (ru) Модуляторы пути системы комплемента и их применение
MX366230B (es) Composiciones multipolimericas para liberación transdermica de farmaco.
WO2014153009A3 (en) Thiosaccharide mucolytic agents
AR101236A1 (es) Composiciones para el cuidado oral
AR081015A1 (es) Formulaciones de galactomananos oftalmicas estabilizadas. metodo.
NZ709620A (en) Pharmaceutical formulation comprising an insoluble corticosteroid and a soluble corticosteroid
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
BR112016024400A2 (pt) uso de niacinamida, niacinamida e método para melhorar a proteção do couro cabeludo
MX2017004772A (es) Composiciones y métodos para la administración fisiológica utilizando cannabidiol.
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
IN2013MU03583A (es)
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
CY1121973T1 (el) Θεραπεια φαρμακευτικα ανθεκτικου καρκινου η οποια στοχευει καρκινικα βλαστοκυτταρα
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
MX342930B (es) Composicion reticuladora mejorada, suministrada por iontoforesis, util para el tratamiento de queratocono.
UY35307A (es) Composición antifúngica tópica para el tratamiento de onicomicosis
AR094224A1 (es) Composicion farmaceutica en forma de una suspension oral
CY1122538T1 (el) Συμπλεγματα χονδροϊτινης για διαδερμικη απορροφηση
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses

Legal Events

Date Code Title Description
FB Suspension of granting procedure